Ann Dermatol.  2016 Dec;28(6):677-683. 10.5021/ad.2016.28.6.677.

A Study of Intravenous Administration of Vitamin C in the Treatment of Acute Herpetic Pain and Postherpetic Neuralgia

• Kim MS
• Kim DJ
• Na CH
• Shin BS

• KMID: 2368116
• DOI: http://doi.org/10.5021/ad.2016.28.6.677

Abstract

BACKGROUND
Although there are several available management strategies for treatment of both acute pain of herpes zoster (HZ) and postherpetic neuralgia (PHN), it is difficult to treat them adequately.
OBJECTIVE
The aim of this study was to evaluate the efficacy of intravenously administrated vitamin C on acute pain and its preventive effects on PHN in patients with HZ.
METHODS
Between September 2011 and May 2013 eighty-seven patients who were admitted for HZ were assessed according to age, sex, underlying diseases, duration of pain and skin lesion, dermatomal distribution, and PHN. It was a randomized controlled study, in which 87 patients were randomly allocated into the ascorbic acid group and control group. Each patient received normal saline infusion with or without 5 g of ascorbic acid on days 1, 3, and 5 then answered questionnaires that included side effects and pain severity using visual analogue scale on days 1, 2, 3, 4, and 5. After discharge, the severity of pain was obtained at out-patient clinic or by telephone on weeks 2, 4, 8, and 16.
RESULTS
There was no differences in severity of pain on patients' age, sex, underlying diseases, duration of pain and skin lesion and dermatomal distribution between two groups (p>0.05). Since 8th week, pain score in ascorbic acid treatment group was significantly lower than control group (p <0.05). The incidence of PHN was significantly lower in the treatment group compared to control group (p=0.014). The changes of overall pain score was significantly different between the two groups (p<0.05).
CONCLUSION
Intravenously administered ascorbic acid did not relieve acute HZ pain; but is effective for reducing the incidence of PHN.

Keyword

Ascorbic acid; Herpes zoster; Postherpetic neuralgia

MeSH Terms

Acute Pain
Administration, Intravenous*
Ascorbic Acid*
Herpes Zoster
Humans
Incidence
Neuralgia, Postherpetic*
Outpatients
Skin
Telephone
Vitamins*
Ascorbic Acid
Vitamins

Figure

• 

  Fig. 1 The pain score in the vitamin C treatment group and control group. HD: hospital date, W: week.

• 

  Fig. 2 The pain score change in vitamin C group. (A) In the age <60 and age ≥60 groups. (B) In the female and male groups. (C) Five days before and after pain. (D) Seventy-two hours within and over skin lesion. (E) In the underlying diseases. Means and standard errors are shown. p-value was calculated by repeated-measures analysis of variance (RM ANOVA). HD: hospital date, W: week.

Reference

1. Choi WS. Herpes zoster vaccine in Korea. Clin Exp Vaccine Res. 2013; 2:92–96.

2. Song H, Lee J, Lee M, Choi WS, Choi JH, Lee MS, et al. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study. Int J Infect Dis. 2014; 20:23–30.

3. Schmader KE, Oxman MN. Varicella and herpes zoster. In : Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw-Hill;2012. p. 2383–2401.

4. Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis. 2004; 39:342–348.

5. Tyring SK. Management of herpes zoster and postherpetic neuralgia. J Am Acad Dermatol. 2007; 57:S136–S142.

6. Harpaz R, Ortega-Sanchez IR, Seward JF. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008; 57:1–30. quiz CE2-CE4.

7. Falaki F, Nejat AH, Dalirsani Z. The effect of low-level laser therapy on trigeminal neuralgia: a review of literature. J Dent Res Dent Clin Dent Prospects. 2014; 8:1–5.

8. Jain SK, Pemberton PW, Smith A, McMahon RF, Burrows PC, Aboutwerat A, et al. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol. 2002; 36:805–811.

9. Terekhina NA, Petrovich IuA, Batueva RA, Sosnin DIu, Vesna VA. [Lacrimal and salivary antioxidants in viral infection]. Klin Lab Diagn. 1998; (1):13–15.

10. Chen JY, Chu CC, Lin YS, So EC, Shieh JP, Hu ML. Nutrient deficiencies as a risk factor in Taiwanese patients with postherpetic neuralgia. Br J Nutr. 2011; 106:700–707.

11. Schencking M, Vollbracht C, Weiss G, Lebert J, Biller A, Goyvaerts B, et al. Intravenous vitamin C in the treatment of shingles: results of a multicenter prospective cohort study. Med Sci Monit. 2012; 18:CR215–CR224.

12. Byun SH, Jeon Y. Administration of vitamin C in a patient with Herpes Zoster-a case report-. Korean J Pain. 2011; 24:108–111.

13. Schencking M, Sandholzer H, Frese T. Intravenous administration of vitamin C in the treatment of herpetic neuralgia: two case reports. Med Sci Monit. 2010; 16:CS58–CS61.

14. Peek DF, van Zundert J. The vitamin C controversy. Clin J Pain. 2010; 26:551–552. author reply 552-553.

15. Katz J, Melzack R. Measurement of pain. Surg Clin North Am. 1999; 79:231–252.

16. Kim YJ, Lee CN, Lim CY, Jeon WS, Park YM. Population-based study of the epidemiology of herpes zoster in Korea. J Korean Med Sci. 2014; 29:1706–1710.

17. Roh NK, Park YM, Kang H, Choi GS, Kim BJ, Lee YW, et al. Awareness, knowledge, and vaccine acceptability of Herpes Zoster in Korea: a multicenter survey of 607 patients. Ann Dermatol. 2015; 27:531–538.

18. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007; 82:1341–1349.

19. Kawai K, Rampakakis E, Tsai TF, Cheong HJ, Dhitavat J, Covarrubias AO, et al. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia. Int J Infect Dis. 2015; 34:126–131.

20. Chen JY, Chang CY, Feng PH, Chu CC, So EC, Hu ML. Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain. Clin J Pain. 2009; 25:562–569.

21. Chung JM. The role of reactive oxygen species (ROS) in persistent pain. Mol Interv. 2004; 4:248–250.

22. Mikirova N, Hunninghake R. Effect of high dose vitamin C on Epstein-Barr viral infection. Med Sci Monit. 2014; 20:725–732.

23. Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One. 2010; 5:e11414.